Baxter International (BAX) Operating Expenses (2009 - 2026)

Baxter International (BAX) has 18 years of Operating Expenses data on file, last reported at $867.0 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $867.0 million, up 2.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $867.0 million (up 2.85% YoY), and the FY2025 annual result was $3.4 billion, down 4.19% from the prior year.
• Operating Expenses grew to $867.0 million in Q1 2026 per BAX's latest filing, from $843.0 million in the prior quarter.
• Over five years, Operating Expenses peaked at $1.2 billion in Q1 2024 and troughed at $15.0 million in Q4 2023.
• A 5-year average of $903.4 million and a median of $1.1 billion in 2022 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2022 and 2023: Operating Expenses surged 59.21% in 2022, then plunged 89.36% in 2023.
• A 5-year view of Operating Expenses shows it stood at $141.0 million in 2022, then sank by 89.36% to $15.0 million in 2023, then jumped by 7920.0% to $1.2 billion in 2024, then declined by 29.93% to $843.0 million in 2025, then rose by 2.85% to $867.0 million in 2026.
• Business Quant data shows BAX's Operating Expenses at $867.0 million in Q1 2026, $843.0 million in Q1 2025, and $1.2 billion in Q1 2024.